fluconazole has been researched along with Cancer of Oropharnyx in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramirez-Amador, V | 1 |
| Silverman, S | 1 |
| Mayer, P | 1 |
| Tyler, M | 1 |
| Quivey, J | 1 |
1 other study available for fluconazole and Cancer of Oropharnyx
| Article | Year |
|---|---|
Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; Candida albicans; Candidias | 1997 |